| 证券代码 | NVTR.O |
| 证券名称 | Nuvectra Corp |
| 证券类型 | 美股 |
| 上市场所 | 纳斯达克交易所 |
| 上市板块 | - |
| 发行方式 | - |
| 首发上市日 | 2016-03-14 |
| 首发价格(元) | - |
| 首发数量(股) | 0 |
| 首发募资额(元) | - |
| 首发主承销商 | - |
| 货币单位 | USD |
| 公司名称 | Nuvectra Corporation |
| 注册地址 | 美国特拉华州 |
| 办公地址 | 5830 Granite Parkway, Suite 1100, Plano, Texas, USA |
| 成立日期 | 2008-11-14 |
| 董事会主席 | Anthony P. Bihl III |
| 公司属地 | United States 美国 |
| 公司网址 | www.nuvectramed.com |
| 电话 | +1 (214) 474-3103 |
| 传真 | - |
| 公司简介 | Nuvectra Corporation is a neurostimulation company committed to helping physicians improve the lives of people with chronic neurological conditions. The Algovita Spinal Cord Stimulation (SCS) System is its first commercial offering and is CE marked and FDA approved for the treatment of chronic pain of the trunk and/or limbs. Its innovative technology platform also has capabilities under development to support other neurological indications such as sacral nerve stimulation (SNS), and deep brain stimulation (DBS). In addition, its NeuroNexus subsidiary designs, manufactures and markets leading-edge neural-interface technologies for the neuroscience clinical research market. |